{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-034191","form_type":"8-K","ticker":"VBIO","cik":"0001787740","company_name":"Valion Bio, Inc.","filed_at":"2025-03-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.868838+00:00","generated_at":"2026-05-25T07:06:18.406566+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Tivic Health presents data showing personalized VNS nearly doubles HRV in 60% of participants","bullets":["Data from Feinstein Institute collaboration presented at Sixth Bioelectronic Medicine Summit.","Personalized ncVNS frequency optimized HRV change; no single frequency universally dominant.","60% of participants (responders) saw raw HRV nearly double on average post-stimulation.","Normalized HRV increased 2.67x, indicating enhanced vagal tone and improved autonomic balance.","Company believes findings support non-invasive devices for inflammatory, cardiac, neurologic disorders."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-034191","json":"https://secwatch.observer/filing/0000950170-25-034191.json","markdown":"https://secwatch.observer/filing/0000950170-25-034191.md","text":"https://secwatch.observer/filing/0000950170-25-034191.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1787740/000095017025034191/0000950170-25-034191-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1787740/000095017025034191/tivc-20250306.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T07:06:18.406566+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}